ASXC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ASXC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-06-08), Asensus Surgical's current share price is $0.332. Asensus Surgical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $0.44. Asensus Surgical's Cyclically Adjusted PS Ratio for today is 0.75.
The historical rank and industry rank for Asensus Surgical's Cyclically Adjusted PS Ratio or its related term are showing as below:
During the past years, Asensus Surgical's highest Cyclically Adjusted PS Ratio was 17.56. The lowest was 0.08. And the median was 1.33.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Asensus Surgical's adjusted revenue per share data for the three months ended in Mar. 2024 was $0.004. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.44 for the trailing ten years ended in Mar. 2024.
The historical data trend for Asensus Surgical's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asensus Surgical Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted PS Ratio | Get a 7-Day Free Trial | 0.45 | 0.99 | 0.61 | 0.73 | 0.52 |
For the Medical Devices subindustry, Asensus Surgical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Asensus Surgical's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Asensus Surgical's Cyclically Adjusted PS Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
Asensus Surgical's Cyclically Adjusted PS Ratio for today is calculated as
Cyclically Adjusted PS Ratio | = | Share Price | / | Cyclically Adjusted Revenue per Share |
= | 0.332 | / | 0.44 | |
= | 0.75 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asensus Surgical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, Asensus Surgical's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:
Adj_RevenuePerShare | = | Revenue per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 0.004 | / | 131.7762 | * | 131.7762 | |
= | 0.004 |
Current CPI (Mar. 2024) = 131.7762.
Asensus Surgical Quarterly Data
Revenue per Share | CPI | Adj_RevenuePerShare | |
201406 | 0.025 | 100.560 | 0.033 |
201409 | 0.013 | 100.428 | 0.017 |
201412 | 0.028 | 99.070 | 0.037 |
201503 | 0.000 | 99.621 | 0.000 |
201506 | 0.000 | 100.684 | 0.000 |
201509 | 0.000 | 100.392 | 0.000 |
201512 | 0.000 | 99.792 | 0.000 |
201603 | 0.000 | 100.470 | 0.000 |
201606 | 0.000 | 101.688 | 0.000 |
201609 | 0.166 | 101.861 | 0.215 |
201612 | 0.006 | 101.863 | 0.008 |
201703 | 0.208 | 102.862 | 0.266 |
201706 | 0.156 | 103.349 | 0.199 |
201709 | 0.016 | 104.136 | 0.020 |
201712 | 0.231 | 104.011 | 0.293 |
201803 | 0.310 | 105.290 | 0.388 |
201806 | 0.406 | 106.317 | 0.503 |
201809 | 0.337 | 106.507 | 0.417 |
201812 | 0.455 | 105.998 | 0.566 |
201903 | 0.131 | 107.251 | 0.161 |
201906 | 0.216 | 108.070 | 0.263 |
201909 | 0.114 | 108.329 | 0.139 |
201912 | 0.035 | 108.420 | 0.043 |
202003 | 0.021 | 108.902 | 0.025 |
202006 | 0.013 | 108.767 | 0.016 |
202009 | 0.008 | 109.815 | 0.010 |
202012 | 0.011 | 109.897 | 0.013 |
202103 | 0.010 | 111.754 | 0.012 |
202106 | 0.005 | 114.631 | 0.006 |
202109 | 0.011 | 115.734 | 0.013 |
202112 | 0.011 | 117.630 | 0.012 |
202203 | 0.005 | 121.301 | 0.005 |
202206 | 0.004 | 125.017 | 0.004 |
202209 | 0.011 | 125.227 | 0.012 |
202212 | 0.010 | 125.222 | 0.011 |
202303 | 0.004 | 127.348 | 0.004 |
202306 | 0.005 | 128.729 | 0.005 |
202309 | 0.004 | 129.860 | 0.004 |
202312 | 0.021 | 129.419 | 0.021 |
202403 | 0.004 | 131.776 | 0.004 |
Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Thank you for viewing the detailed overview of Asensus Surgical's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Starling William N Jr | director | 2300 BUCKSKIN ROAD, POCATELLO ID 83201 |
Andrea Biffi | director | C/O SOFAR SPA, VIA FIRENZE 40, TREZZANO ROSA (MI) L6 20060 |
Elizabeth Kwo | director | C/O FLEXION THERAPEUTICS, INC., 10 MALL ROAD, SUITE 301, BURLINGTON MA 01803 |
David Bruce Milne | director | ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108 |
Kevin J Hobert | director | 343 STATE STREET, ROCHESTER NY 14650 |
Fernando Anthony C. J. | officer: Chief Technology Officer | 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560 |
Rampertab Shameze | officer: EVP, Chief Financial Officer | C/O ZOMEDICA PHARMACEUTICALS CORP., 3928 VARSITY DRIVE, ANN ARBOR MI 48108 |
Brett Farabaugh | officer: Interim CFO | 108 T.W. ALEXANDER DRIVE, RESEARCH TRIANGLE PARK NC 27709 |
Joseph P Slattery | officer: EVP and CFO | C/O TRANSENTERIX, INC., 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560 |
Eric A Smith | officer: Chief Commercial Officer | 7 CALEB CIRCLE, SAN ANTONIO TX 78258 |
Todd Pope | director, officer: President and CEO | C/O TRANSENTERIX, 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27713 |
Willam N Kelley | director | MERCK & CO., INC., ONE MERCK DRIVE, WHITEHOUSE STATION X1 08889 |
Pfenniger Richard C Jr | director | 4400 BISCAYNE BLVD., MIAMI FL 33137 |
Sofar, S.p.a | 10 percent owner | VIA FIRENZE 40, TREZZANO ROSA L6 20060 |
Andrew N Schiff | director, 10 percent owner | PLANET ZANETT INC, 135 E 57TH ST, NEW YORK NY 10022 |
From GuruFocus
By PRNewswire PRNewswire • 01-05-2021
By GF Value GF Value • 05-16-2021
By GuruFocusNews GuruFocusNews • 06-28-2022
By Barry Cohen Barry Cohen • 12-23-2020
By GuruFocusNews GuruFocusNews • 07-08-2022
By GF Value • 06-22-2021
By PRNewswire PRNewswire • 03-19-2019
By PRNewswire PRNewswire • 01-11-2021
By Marketwired Marketwired • 04-17-2019
By PRNewswire PRNewswire • 07-28-2021